尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Chung Jane. Insider active across 1 company, notably Sutro Biopharma, INC.. In total, 14 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 9 August 2022. The latest transaction was disclosed on 4 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Jane Chung is a declarant linked to Sutro Biopharma, INC. on XNAS, where the listed role is PRESIDENT AND COO. The record shows 9 filings in total, and the 9 sampled filings cover the period from 2022-08-10 to 2025-03-06, with the modal transaction nature listed as option exercise.